X4 Pharmaceuticals (XFOR) to Offer Common Stock and Warrants

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. SPY
7. CVS
8. UNH
9. ZETA
10. DAL

Go back to X4 Pharmaceuticals (XFOR) to Offer Common Stock and Warrants

X4 Pharmaceuticals Announces Proposed Public Offering

November 25, 2019 4:00 PM EST

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics for the treatment of rare diseases, announced today that it has commenced an underwritten public offering of shares of its common stock (or pre-funded warrants to purchase its common stock in lieu thereof) and Class B warrants to purchase its common stock. All of the securities in the offering will be sold by X4. The offering is subject to market and other conditions, and there can... More